Inventor · disambiguated record
Kathy Fosnaugh
Also filed as: FOSNAUGH KATHY · FOSNAUGH KATHY L · FOSNAUGH KATHY LYNN
6 granted patents·27 pending applications·72 citations·filing 2002–2017
83Inventor score
Top patents by PatentIndex Score
33 records- 0195US8501824B2Amino acid lipids and uses thereofQUAY STEVEN C·Filed 2011·Granted Aug 6, 2013·48 cites·27 claims
- 0291US7939505B2Amino acid lipids and uses thereofMARINA BIOTECH INC·Filed 2008·Granted May 10, 2011·17 cites·31 claims
- 0383US8877729B2Amino acid lipids and uses thereofMARINA BIOTECH INC·Filed 2013·Granted Nov 4, 2014·4 cites·20 claims
- 0478US9339461B2Arginine-based lipids for delivery of therapeuticsMARINA BIOTECH INC·Filed 2014·Granted May 17, 2016·2 cites·20 claims
- 0570US2006292691A1RNA interference mediated inhibition of gene expression using chemically modified short interfering nucleic acid (siNA)SIRNA THERAPEUTICS INC·Filed 2006·Application pending·0 cites
- 0670US2007004667A1RNA interference mediated inhibition of gene expression using chemically modified short interfering nucleic acid (siNA)SIRNA THERAPEUTICS INC·Filed 2006·Application pending·0 cites
- 0768US2006247429A1RNA interference mediated inhibition of gene expression using chemically modified short interfering nucleic acid (siNA)SIRNA THERAPEUTICS INC·Filed 2006·Application pending·0 cites
- 0868US2006287266A1RNA interference mediated ihibition of gene expression using chemically modified short interfering nucleic acid (siNA)SIRNA THERAPEUTICS INC·Filed 2006·Application pending·0 cites
- 0968US2006217336A1RNA interference mediated inhibition of gene expression using chemically modified short interfering nucleic acid (siNA)SIRNA THERAPEUTICS INC·Filed 2006·Application pending·0 cites
- 1067US10023863B2Therapeutics with conformationally restricted monomersMARINA BIOTECH INC·Filed 2015·Granted Jul 17, 2018·1 cites·10 claims
- 1165US2006281175A1RNA interference mediated inhibition of gene expression using chemically modified short interfering nucleic acid (siNA)SIRNA THERAPEUTICS INC·Filed 2006·Application pending·0 cites
- 1265US2006275903A1RNA interference mediated inhibition of gene expression using chemically modified short interfering nucleic acid (siNA)SIRNA THERAPEUTICS INC·Filed 2006·Application pending·0 cites
- 1363US2006217337A1RNA interference mediated inhibition of gene expression using chemically modified short interfering nucleic acid (siNA)SIRNA THERAPEUTICS INC·Filed 2006·Application pending·0 cites
- 1463US2006247428A1RNA interference mediated inhibition of gene expression using chemically modified short interfering nucleic acid (siNA)SIRNA THERAPEUTICS INC·Filed 2006·Application pending·0 cites
- 1563US2006217335A1RNA interference mediated inhibition of gene expression using chemically modified short interfering nucleic acid (siNA)SIRNA THERAPEUTICS INC·Filed 2006·Application pending·0 cites
- 1663US2006217334A1RNA interference mediated inhibition of gene expression using chemically modified short interfering nucleic acid (siNA)SIRNA THERAPEUTICS INC·Filed 2006·Application pending·0 cites
- 1761US2018353607A1Lipids for delivery of therapeuticsMARINA BIOTECH INC·Filed 2017·Application pending·0 cites
- 1860US9731016B2Tyrosine-based lipids for delivery of therapeuticsMARINA BIOTECH INC·Filed 2016·Granted Aug 15, 2017·0 cites·17 claims
- 1960US2003148507A1RNA interference mediated inhibition of prostaglandin D2 receptor (PTGDR) and prostaglandin D2 synthetase (PTGDS) gene expression using short interfering RNARIBOZYME PHARM INC·Filed 2002·Application pending·0 cites
- 2059US2007026394A1Modulation of gene expression associated with inflammation proliferation and neurite outgrowth using nucleic acid based technologiesBLATT LAWRENCE·Filed 2002·Application pending·0 cites
- 2159US2003143732A1RNA interference mediated inhibition of adenosine A1 receptor (ADORA1) gene expression using short interfering RNAFiled 2002·Application pending·0 cites
- 2259US2003191077A1Method and reagent for the treatment of asthma and allergic conditionsFiled 2002·Application pending·0 cites
- 2357US2015073038A1Delivery molecules for therapeuticsMARINA BIOTECH INC·Filed 2014·Application pending·0 cites
- 2453US2011136233A1Nucleic acid compounds for inhibiting plk1 gene expression and uses thereofMARINA BIOTECH INC·Filed 2009·Application pending·0 cites
- 2552US2015105445A1RNA INTERFERENCE MEDIATED INHIBITION OF GENE EXPRESSION USING CHEMICALLY MODIFIED SHORT INTERFERING NUCLEIC ACID (siNA)SIRNA THERAPEUTICS INC·Filed 2014·Application pending·0 cites
- 2651US2017216227A1Delivery molecules for therapeuticsMARINA BIOTECH INC·Filed 2017·Application pending·0 cites
- 2751US2011236972A1Nucleic acid compounds for inhibiting birc5 gene expression and uses thereofMARINA BIOTECH INC·Filed 2009·Application pending·0 cites
- 2850US2005020525A1RNA interference mediated inhibition of gene expression using chemically modified short interfering nucleic acid (siNA)SIRNA THERAPEUTICS INC·Filed 2004·Application pending·0 cites
- 2950US2005176024A1RNA interference mediated inhibition of epidermal growth factor receptor (EGFR) gene expression using short interfering nucleic acid (siNA)SIRNA THERAPEUTICS INC·Filed 2004·Application pending·0 cites
- 3047US2012277289A1Activity generating delivery moleculesFAM RENATA·Filed 2010·Application pending·0 cites
- 3143US2013190383A1Nucleic acid compounds with conformationally restricted monomers and uses thereofVAISH NARENDRA K·Filed 2011·Application pending·0 cites
- 3243US2010305191A1Rna interference mediated inhibition of adenosine a1 receptor (adora1) gene expression using short interfering rnaMCSWIGGEN JAMES·Filed 2010·Application pending·0 cites
- 3343US2008039414A1RNA interference mediated inhibition of gene expression using chemically modified short interfering nucleic acid (siNA)SIRNA THERAPEUTICS INC·Filed 2003·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Kathy Fosnaugh files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →